Latest LDN news summary

A board to discuss Low Dose Naltrexone (LDN) as a treatment for Multiple Sclerosis

Latest LDN news summary

Postby SammyJo » Fri Oct 15, 2004 9:56 am

Feel free to pass on to others:

1. The journal 'Medical Hypotheses' has accepted an LDN/MS hypothesis for publication. Will be public in a few months.

2. The MS center at Univ. Texas is planning a full clinical trial of LDN for MS, after seeing my rapid recovery from secondary progressive MS on LDN. I am happy to answer any questions, my story and email is at

3. Sourasky Medical Center in Israel has completed an Irritable Bowel Syndrome clinical study, reporting a 76% response rate to PTI-901 (LDN), citing ability to balance opioid activity.

4. In the UK, the LDN Research Trust has secured research interest from Drs. Coles and Lawrence.
Coles is a neurologist at Addenbrookes Hospital and advisor to the UK MS Society. LDN users can help by answering their survey

5. Of the 267 LDN users who took the survey - 76% felt LDN made their MS better. There are thousands using LDN for MS and other autoimmune disorders. My pharmacy alone has filled over 2800 LDN prescriptions this year. I have a new survey for LDN users measuring change in EDSS after LDN. Visit

If we keep at this, the research will catch up to us!
User avatar
Family Elder
Posts: 211
Joined: Wed Mar 10, 2004 3:00 pm


Postby Arron » Fri Oct 15, 2004 12:35 pm

Wonderful work, SammyJo... we are all very proud and thankful for your efforts...
User avatar
Volunteer Moderator
Posts: 893
Joined: Sun Feb 01, 2004 3:00 pm
Location: California, USA

Return to Low Dose Naltrexone

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service